OncoNano Announces $11.7 Million Series A Financing to Support Development of pH-activated Compound Platform for Disease Detection and Treatment By Amy MartinezPress Releases SOUTHLAKE, TX. – May 17, 2018 – OncoNano Medicine, Inc. today announced the closing of...Read More May 17, 2018 Love0